Cargando…

Systematic Review of Cholinesterase Inhibitors on Cognition and Behavioral Symptoms in Patients of Chinese Descent with Alzheimer’s Disease, Vascular Dementia, or Mixed Dementia

Cholinesterase inhibitors (ChEIs) are the primary pharmacologic treatment for dementia. Their efficacy in patients of Chinese descent is not well described. We reviewed how ChEIs could affect cognition and behavioral and psychological symptoms (BPSD) in Chinese patients with Alzheimer’s disease (AD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Ka-Chun, Li, Victor, Ng, Yuey-Zhun, Chan, Tsz-Tai, Chang, Richard S., Wong, Roger Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371124/ https://www.ncbi.nlm.nih.gov/pubmed/31011039 http://dx.doi.org/10.3390/geriatrics2030029

Ejemplares similares

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Mok, Vincent, et al.
Publicado: (2007)

Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson’s Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage
por: Zou, Jing, et al.
Publicado: (2018)

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia
por: Ying, Chunwei, et al.
Publicado: (2023)

Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program
por: Piovesana, Magda Cristina Flaitt Sanches, et al.
Publicado: (2012)

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
por: Ortner, Marion, et al.
Publicado: (2020)

PT585. Effect of Neuropsychiatric Symptoms on Mortality in Patients with Dementia: differences between Alzheimer’s dementia, subcortical vascular dementia, and frontotemporal dementia
por: Choi, Booyeol, et al.
Publicado: (2016)

Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia
por: Tayler, Hannah, et al.
Publicado: (2021)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

The brain lipidomes of subcortical ischemic vascular dementia and mixed dementia()
por: Lam, Sin Man, et al.
Publicado: (2014)

Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
por: Maclin, Joshua Marvin Anthony, et al.
Publicado: (2019)

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019)

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
por: Hoffmann, Falk, et al.
Publicado: (2011)

Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
por: Balázs, Nóra, et al.
Publicado: (2021)

Alzheimer and vascular dementia in the elderly patients
por: Seetlani, Naresh Kumar, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias
por: Muayqil, Taim, et al.
Publicado: (2012)

Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia
por: Moretti, Rita, et al.
Publicado: (2017)

Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer’s Disease, Pure Subcortical Vascular Dementia, and Mixed Dementia
por: Jang, Hyemin, et al.
Publicado: (2017)

RBC acetyl cholinesterase: A poor man's early diagnostic biomarker for familial alzheimer's and Parkinson's disease dementia
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2015)

Predictors of the Progression of Dementia Severity in Brazilian Patients with Alzheimer's Disease and Vascular Dementia
por: Chaves, Márcia L., et al.
Publicado: (2010)

OUTCOMES OF DISCONTINUING CHOLINESTERASE INHIBITORS IN NURSING HOME RESIDENTS WITH SEVERE DEMENTIA
por: Niznik, Joshua D, et al.
Publicado: (2019)

Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
por: Fallon, Sean James, et al.
Publicado: (2023)

The Closing-in Phenomenon in Alzheimer's Disease and Vascular Dementia
por: Chin, Juhee, et al.
Publicado: (2005)

Global Epidemiology of Dementia: Alzheimer's and Vascular Types
por: Rizzi, Liara, et al.
Publicado: (2014)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

Alzheimer and vascular brain disease: Senile dementia
por: Engelhardt, Eliasz, et al.
Publicado: (2015)

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
por: Shabir, Osman, et al.
Publicado: (2018)

Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
por: Gustavsson, Anna‐Märta, et al.
Publicado: (2019)

Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia
por: Pan, Wei-Dong, et al.
Publicado: (2013)

Depression in elderly patients with Alzheimer dementia or vascular dementia and its influence on their quality of life
por: Winter, Yaroslav, et al.
Publicado: (2011)

Hypertensive disorders of pregnancy and risk of Alzheimer’s disease, vascular dementia, and other related dementia
por: Schliep, Karen, et al.
Publicado: (2021)

Gout and risk of dementia, Alzheimer's disease or vascular dementia: a meta-epidemiology study
por: Li, Xuanlin, et al.
Publicado: (2023)

Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015)

Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients
por: Hashimoto, Mamoru, et al.
Publicado: (2015)

Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study
por: Olazarán, Javier, et al.
Publicado: (2013)

Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia
por: Carter, Elizabeth, et al.
Publicado: (2020)

"Closing-in" phenomenon in Alzheimer's disease and subcortical vascular dementia
por: Kwak, Yong Tae
Publicado: (2004)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Bandyopadhyay, Tushar Kanti, et al.
Publicado: (2014)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Raina, Sunil Kumar
Publicado: (2015)

Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia
por: Wang, Zhiyong, et al.
Publicado: (2023)

Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
por: Secnik, Juraj, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o6ghsol698t8sn67384751engt